Cancer
Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine (VNP40101M) in Elderly AML
Published in Biotech Law Weekly, August 31st, 2007
Alan Kessman, Chief Executive Officer said, "We are extremely pleased to have reached this milestone in the pivotal Phase II trial of our lead anticancer agent. We will now proceed to analyze the data and, if warranted, prepare a New Drug Application for submission to the U.S. Food and Drug Administration in 2008." He added, "We continue to plan on the release of preliminary data from this trial...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2007-08-31)
More Articles from Biotech Law Weekly
- Acara Partners
Acara Expands to Nationwide Search for Its Medical Spa Acquisition Strategy - ADA Watch Coalition and National Coalition for Disability Rights
Senator Tom Harkin Calls for Restoration of Americans with Disabilities Act on the 'Road to Freedom' National Bus Tour - Addiction Medicine
Online Tool Educates MySpace Generation about Opioid Addiction - Amvets
AMVETS to Step Up Recruitment of Younger Veterans as it Fights for Mandatory Funding of Veterans Healthcare - Autism
Deirdre Imus, Katie Wright to Speak at '07 National Autism Conference, Atlanta - Bally Total Fitness
Bally Total Fitness Announces Noteholder Support for Proposed Amendments to Plan of Reorganization Sponsored by Harbinger Capital Partners Funds - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
